ReviewThe EMBO journal2026

eIF3 musketeers: loyal in health, rogue in disease, and redeemed by therapeutic targeting.

Reza Mohammadinejad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.